Charles Schwab’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $31.8M | Buy |
575,364
+17,646
| +3% | +$975K | 0.01% | 1398 |
|
|
2025
Q1 | $27M | Sell |
557,718
-20,691
| -4% | -$1M | 0.01% | 1457 |
|
|
2024
Q4 | $22.3M | Buy |
578,409
+12,906
| +2% | +$498K | ﹤0.01% | 1638 |
|
|
2024
Q3 | $25.4M | Buy |
565,503
+39,850
| +8% | +$1.79M | ﹤0.01% | 1560 |
|
|
2024
Q2 | $18.2M | Buy |
525,653
+29,091
| +6% | +$1.01M | ﹤0.01% | 1739 |
|
|
2024
Q1 | $14.4M | Buy |
496,562
+41,241
| +9% | +$1.19M | ﹤0.01% | 1799 |
|
|
2023
Q4 | $10.4M | Buy |
455,321
+16,219
| +4% | +$372K | ﹤0.01% | 1958 |
|
|
2023
Q3 | $7.32M | Buy |
439,102
+19,492
| +5% | +$325K | ﹤0.01% | 2079 |
|
|
2023
Q2 | $11.6M | Buy |
419,610
+58,452
| +16% | +$1.61M | ﹤0.01% | 1845 |
|
|
2023
Q1 | $8.31M | Buy |
361,158
+21,137
| +6% | +$486K | ﹤0.01% | 1960 |
|
|
2022
Q4 | $3.71M | Buy |
340,021
+6,378
| +2% | +$69.6K | ﹤0.01% | 2357 |
|
|
2022
Q3 | $2.81M | Buy |
333,643
+8,885
| +3% | +$74.9K | ﹤0.01% | 2479 |
|
|
2022
Q2 | $2.57M | Sell |
324,758
-501
| -0.2% | -$3.96K | ﹤0.01% | 2484 |
|
|
2022
Q1 | $7.7M | Buy |
325,259
+8,080
| +3% | +$191K | ﹤0.01% | 2078 |
|
|
2021
Q4 | $10.8M | Buy |
317,179
+7,347
| +2% | +$251K | ﹤0.01% | 1959 |
|
|
2021
Q3 | $5.49M | Buy |
309,832
+28,454
| +10% | +$504K | ﹤0.01% | 2331 |
|
|
2021
Q2 | $12.6M | Buy |
281,378
+19,791
| +8% | +$888K | ﹤0.01% | 1879 |
|
|
2021
Q1 | $6.78M | Buy |
261,587
+36,367
| +16% | +$942K | ﹤0.01% | 2150 |
|
|
2020
Q4 | $4.54M | Buy |
225,220
+8,734
| +4% | +$176K | ﹤0.01% | 2265 |
|
|
2020
Q3 | $4.23M | Buy |
216,486
+159,414
| +279% | +$3.12M | ﹤0.01% | 2146 |
|
|
2020
Q2 | $1.01M | Buy |
57,072
+13,168
| +30% | +$233K | ﹤0.01% | 2624 |
|
|
2020
Q1 | $310K | Buy |
43,904
+151
| +0.3% | +$1.07K | ﹤0.01% | 2883 |
|
|
2019
Q4 | $309K | Buy |
43,753
+3,139
| +8% | +$22.2K | ﹤0.01% | 2964 |
|
|
2019
Q3 | $488K | Buy |
40,614
+4,145
| +11% | +$49.8K | ﹤0.01% | 2811 |
|
|
2019
Q2 | $442K | Buy |
+36,469
| New | +$442K | ﹤0.01% | 2865 |
|
|
2018
Q2 | – | Sell |
-32,315
| Closed | -$278K | – | 3141 |
|
|
2018
Q1 | $278K | Buy |
32,315
+13,015
| +67% | +$112K | ﹤0.01% | 2899 |
|
|
2017
Q4 | $402K | Buy |
19,300
+6,100
| +46% | +$127K | ﹤0.01% | 2782 |
|
|
2017
Q3 | $234K | Hold |
13,200
| – | – | ﹤0.01% | 2966 |
|
|
2017
Q2 | $150K | Hold |
13,200
| – | – | ﹤0.01% | 3068 |
|
|
2017
Q1 | $170K | Hold |
13,200
| – | – | ﹤0.01% | 2955 |
|
|
2016
Q4 | $291K | Buy |
+13,200
| New | +$291K | ﹤0.01% | 2858 |
|